Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Non Operating Income (2016 - 2023)

Pharma-Bio Serv's Non Operating Income history spans 13 years, with the latest figure at $126985.0 for Q3 2023.

  • For Q3 2023, Non Operating Income rose 336.55% year-over-year to $126985.0; the TTM value through Jul 2023 reached $628228.0, up 1426.66%, while the annual FY2022 figure was $13418.0, 99.32% down from the prior year.
  • Non Operating Income reached $126985.0 in Q3 2023 per PBSV's latest filing, down from $192616.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.0 million in Q3 2021 to a low of -$53683.0 in Q3 2022.
  • Average Non Operating Income over 5 years is $165699.7, with a median of $48584.0 recorded in 2020.
  • Peak YoY movement for Non Operating Income: tumbled 136.9% in 2020, then skyrocketed 39988.62% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $57436.0 in 2019, then crashed by 98.88% to $641.0 in 2020, then skyrocketed by 104.37% to $1310.0 in 2021, then soared by 4639.08% to $62082.0 in 2022, then soared by 104.54% to $126985.0 in 2023.
  • Per Business Quant, the three most recent readings for PBSV's Non Operating Income are $126985.0 (Q3 2023), $192616.0 (Q2 2023), and $246545.0 (Q1 2023).